EQS-News: invIOs GmbH / Key word(s): Study results invIOs GmbH: APEIRON Respiratory Therapies announces positive results from Phase I trial of inhaled APN01 03.11.2022 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. APEIRON Respiratory Therapies announce.
- Mitsui Chemicals has invested to support Apeiron's Pan-Asia expansion- Strategic partnership with Mitsui Chemicals will enhance Apeiron's regional scalability and commitment to achieving net-zero emissions
Ancient8 is developing next generation GameFi software for communities, gamers, and games, making it easier for game studios to enter the Web3 era and connect with GameFi communities worldwide. HO CHI MINH CITY, Vietnam, June 9, 2022 /PRNewswire/ Ancient8, a GameFi infrastructure developer and Vietnam's largest blockchain gaming guild and community, today announced the completion of a US$6 million private round of financing led by Makers Fund and C Ventures, with participation from existing and new investors Pantera Capital, 6th Man Ventures, IOSG Ventures, Folius Ventures, Morningstar Ventures, Th3ia Capital, Sky9 Capital, and Play Ventures, among others. Founded in July 2021, Ancient8 is buildingsoftware to create infrastructure for GameFi, with a focus on community and software. Ancient8 helps GameFi studios identify high quality gamers and run Web3-native targeted advertising through the Ancient8 GameFi Identity product and Ancient8 Launchpads. For gamers and crypto communitie